Načítá se...
5-Hydroxymethylcytosine is an independent predictor of survival in malignant melanoma
Outcomes for melanoma patients vary within cancer stage. Prognostic biomarkers are potential adjuncts to provide more precise prognostic information. Simple, low-cost biomarker assays, such as those based on immunohistochemistry, have strong translational potential. 5-hydroxymethylcytosine (5hmC) sh...
Uloženo v:
| Vydáno v: | Mod Pathol |
|---|---|
| Hlavní autoři: | , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6176904/ https://ncbi.nlm.nih.gov/pubmed/27713424 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/modpathol.2016.159 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|